OPKO Health, Inc. OPK, in response to statements regarding the sale of
Company common stock by Mr. Adam E. Logal, OPKO's Vice President, Chief
Accounting Officer and Treasurer, would like to clarify that no other Company
officer has exercised common stock options or sold any shares of Company
common stock during the last twelve months and that the nominal exercise of
50,000 common stock options and sale of such common stock by Mr. Logal was
done to address pressing family circumstances. No other sales by Company
officers or insiders are currently contemplated. Further, Dr. Phillip Frost,
the Company's Chairman and Chief Executive Officer, purchased a total of
11,218,067 shares of the Company's common stock during 2012 and has purchased
a total of 383,500 shares of the Company's common stock so far during 2013.
Dr. Frost, along with other Company officers and insiders, also invested in
the Company's recently completed $175 million convertible debt offering.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in